L

L&C Bio Co Ltd
KOSDAQ:290650

Watchlist Manager
L&C Bio Co Ltd
KOSDAQ:290650
Watchlist
Price: 62 600 KRW -2.95% Market Closed
Market Cap: 1.5T KRW

Wall Street
Price Targets

Price Targets Summary
L&C Bio Co Ltd

There are no price targets for L&C Bio Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
L&C Bio Co Ltd Competitors:
Price Targets
MIRM
Mirum Pharmaceuticals Inc
32% Upside
005690
Pharmicell Co Ltd
14% Upside
CNTB
Connect Biopharma Holdings Ltd
200% Upside
SPRB
Spruce Biosciences Inc
149% Upside
PHIL
Philogen SpA
13% Upside
NRIX
Nurix Therapeutics Inc
47% Upside
NIOX
Niox Group PLC
23% Upside

Revenue
Forecast

Revenue Estimate
L&C Bio Co Ltd

For the last 8 years the compound annual growth rate for L&C Bio Co Ltd's revenue is 25%. The projected CAGR for the next 3 years is 23%.

25%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
L&C Bio Co Ltd

For the last 8 years the compound annual growth rate for L&C Bio Co Ltd's operating income is 3%. The projected CAGR for the next 3 years is 73%.

3%
Past Growth
73%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Net Income
Forecast

Net Income Estimate
L&C Bio Co Ltd

For the last 8 years the compound annual growth rate for L&C Bio Co Ltd's net income is 70%. The projected CAGR for the next 3 years is -58%.

70%
Past Growth
-58%
Estimated Growth
Estimates Accuracy
27%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is L&C Bio Co Ltd's stock price target?
Not Available

L&C Bio Co Ltd doesn't have any price targets made by Wall Street professionals.

What is L&C Bio Co Ltd's Revenue forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for L&C Bio Co Ltd's revenue is 25%. The projected CAGR for the next 3 years is 23%.

What is L&C Bio Co Ltd's Operating Income forecast?
Projected CAGR
73%

For the last 8 years the compound annual growth rate for L&C Bio Co Ltd's operating income is 3%. The projected CAGR for the next 3 years is 73%.

What is L&C Bio Co Ltd's Net Income forecast?
Projected CAGR
-58%

For the last 8 years the compound annual growth rate for L&C Bio Co Ltd's net income is 70%. The projected CAGR for the next 3 years is -58%.

Back to Top